We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

152 hedge funds and large institutions have $2.24B invested in Heron Therapeutics in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 19

79% more capital invested

Capital invested by funds: $1.25B → $2.24B (+$991M)

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

38% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 39

23% more funds holding

Funds holding: 124 → 152 (+28)

18.42% more ownership

Funds ownership: 107.15% → 125.57% (+18%)

10% more call options, than puts

Call options by funds: $39.4M | Put options by funds: $35.7M

Holders
152
Holders Change
+28
Holders Change %
+22.58%
% of All Funds
3.48%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
47
Increased
54
Reduced
39
Closed
19
Calls
$39.4M
Puts
$35.7M
Net Calls
+$3.62M
Net Calls Change
-$7.32M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$49.3M
2
BBA
Baker Bros. Advisors
New York
+$44.6M
3
EAM
Eagle Asset Management
Florida
+$41.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$34.7M
5
BM
Bridger Management
New York
+$29M

Top Sellers

1
CC
Carlson Capital
Texas
-$26.2M
2
Franklin Resources
Franklin Resources
California
-$26.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$15.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$15M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
126
SG Americas Securities
New York
$183K +$150K +6,622 New
TRCT
127
Tower Research Capital (TRC)
New York
$160K +$130K +5,725 +5,668%
Bank of Montreal
128
Bank of Montreal
Ontario, Canada
$130K +$17K +750 +19%
Canada Life
129
Canada Life
Manitoba, Canada
$127K -$118K -5,196 -53%
AIP
130
Ameritas Investment Partners
Nebraska
$127K +$23.6K +1,041 +29%
QT
131
Quantbot Technologies
New York
$117K +$96.3K +4,243 New
Zurich Cantonal Bank
132
Zurich Cantonal Bank
Switzerland
$82K – – –
IF
133
Ironwood Financial
Arizona
$58K +$9.26K +408 +24%
JIR
134
James Investment Research
Ohio
$42K +$34.8K +1,535 New
FPF
135
FNY Partners Fund
New York
$40K +$33.2K +1,463 New
Envestnet Asset Management
136
Envestnet Asset Management
Illinois
$37K +$30.4K +1,339 New
SPIA
137
Steward Partners Investment Advisory
New York
$27K – – –
LTFS
138
Ladenburg Thalmann Financial Services
Florida
$19K -$75.9K -3,345 -83%
CHP
139
Cable Hill Partners
Oregon
$17K +$2.88K +127 +25%
Fifth Third Bancorp
140
Fifth Third Bancorp
Ohio
$14K – – –
KBC Group
141
KBC Group
Belgium
$14K – – –
FANJ
142
Financial Architects (New Jersey)
New Jersey
$8K +$6.8K +300 New
AG
143
Advisor Group
Arizona
$7K +$4.63K +204 +434%
Royal Bank of Canada
144
Royal Bank of Canada
Ontario, Canada
$6K -$84.4K -3,720 -95%
VFA
145
Valeo Financial Advisors
Indiana
$6K – – –
APP
146
Avantax Planning Partners
Iowa
$4K +$3.63K +160 New
WAS
147
Winch Advisory Services
Wisconsin
$3K -$4.54K -200 -67%
WT
148
Whittier Trust
California
$2K – – –
MOS
149
MGO One Seven
Ohio
$1K – – –
IFAM
150
Institutional & Family Asset Management
Colorado
$1K +$1.13K +50 New
3 4 5
6
7

HRTX Hedge Fund Activity: Q1 2018 in Review

152 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2018, worth a combined $2.24B — up 79% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new HRTX positions and 19 closed out — a net gain of 28 holders — while 54 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $49.3M. The largest seller was Carlson Capital, cutting an estimated $26.2M.

  • 152 institutional investors held Heron Therapeutics (HRTX) as of Q1 2018, up from 124 in Q4 2017.
  • Funds reported $2.24B of Heron Therapeutics stock for Q1 2018, up 79% quarter-over-quarter.
  • 47 funds opened new Heron Therapeutics positions in Q1 2018 and 19 closed out, a net change of +28 holders.
  • The largest Heron Therapeutics buyer in Q1 2018 was Wellington Management Group, an estimated $49.3M added.
  • The largest Heron Therapeutics seller in Q1 2018 was Carlson Capital, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2018.